PROJECT

Projects

Summary of Investment Information

Project Number

45666

Company Name

BANCO SANTANDER BRASIL SA

Date SPI Disclosed

Oct 11, 2021

Country

Brazil

Region

Latin America and the Caribbean

Projected Board Date

Nov 11, 2021

Environmental Category

FI-2 - Limited

Status

Completed

Last Updated Date

Jun 11, 2025

Department

Regional Industry - FIG LAC

Industry

Financial Markets

Previous Events

Approved : Nov 30, 2021
Signed : Mar 15, 2022
Invested : Mar 17, 2022

Sector

Commercial Banking - General

Project Description

The indicative proposed investment consists of a 3-year loan of up to US$150 million to Banco Santander (Brasil) S.A. (“Santander” or the “Bank”), an existing IFC client since 2009. The Project aims to support the Bank’s consumer finance lending to healthcare services Micro, Small and Medium Enterprises (“MSMEs”) as well as doctors and health professionals to purchase medical equipment (“MedTech”) to meet the increased service demand to fight COVID and further equipping the Brazilian health system for future resilience (“the Project”). In addition, up to 30 percent of the loan may be used to finance working capital needs for MSMEs (MedTech manufacturers or distributors and healthcare services providers). As a result of the proposed use of proceeds, this Project is processed under the Global Health Platform (“GHP”), a US$4 billion IFC program with the objective of mobilizing private investment to close the healthcare supply gaps in the wake of Covid-19.

Associated Advisory Engagement

IFC is currently discussing with Santander possible advisory service for the scope of the Project.

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation